A Curated Platform of Equity & Options Market Intelligence
Select Page

ARVN

Search by
TICKER SYMBOL

Arvinas Inc

Sector: Manufacturing
Industry: Medicinal and Botanical Manufacturing

24.5

0.25

(1.031%)

Volume:

416,192

52 week range:

21.21 - 58.58

Market Cap:

1.308B

Company Description:

arvinas is a pharmaceutical company focused on developing new small molecules ‒ known as protacs (proteolysis targeting chimeras) ‒ aimed at degrading disease-causing cellular proteins via proteolysis. based on innovative research conducted at yale university by dr. craig crews, founder and chief scientific advisor, the company is translating natural protein degradation approaches into novel drugs for the treatment of cancer and other diseases. the proprietary protac-based drug paradigm induces protein degradation, rather than protein inhibition, using the ubiquitin proteasome system and offers the advantage of potentially targeting “undruggable” as well as “druggable” elements of the proteome. this greatly expands the ability to create drugs for many new, previously unapproachable targets. for more information, visit www.arvinas.com.